Historically, engineering CD8+ T cells to express CD4 presents a challenge for HIV treatment due to the likelihood that enhanced CD4 expression would make the transduced CD8+ T cells susceptible to HIV infection [12,78–81] owing to abundant expression of the CCR5 coreceptor [82]. The gene discussed is CD8A; the disease is HIV infectious disease.